Trial Profile
An Open-Label Extension of a Phase II Clinical Trial assessing efficacy with tradipitant in improving nausea and overall symptoms in patients with gastroparesis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Dec 2021
Price :
$35
*
At a glance
- Drugs Tradipitant (Primary)
- Indications Gastroparesis
- Focus Therapeutic Use
- 09 Dec 2021 New trial record
- 27 Oct 2021 Results presented at the American College of Gastroenterology Annual Scientific Meeting and Postgraduate Course 2021